In these studies, PBs were subdivided into two large subgroups: PB-A, clustered together with retinoblastoma, consisted of patients who are diagnosed as “intracranial retinoblastoma” including children with RB1 germline mutation; and PB-B, whose underlying biology was undetermined [75]. Here, RB1 is linked to retinoblastoma.